365 related articles for article (PubMed ID: 30605264)
1. Engineering Immune Tolerance with Biomaterials.
Gammon JM; Jewell CM
Adv Healthc Mater; 2019 Feb; 8(4):e1801419. PubMed ID: 30605264
[TBL] [Abstract][Full Text] [Related]
2. Tissue-Targeted Drug Delivery Strategies to Promote Antigen-Specific Immune Tolerance.
Rui Y; Eppler HB; Yanes AA; Jewell CM
Adv Healthc Mater; 2023 Jan; 12(6):e2202238. PubMed ID: 36417578
[TBL] [Abstract][Full Text] [Related]
3. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
4. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
Edwards C; Carey ST; Jewell CM
ACS Appl Bio Mater; 2023 Jun; 6(6):2017-2028. PubMed ID: 37068126
[TBL] [Abstract][Full Text] [Related]
5. Engineering tolerance using biomaterials to target and control antigen presenting cells.
Tostanoski LH; Gosselin EA; Jewell CM
Discov Med; 2016 May; 21(117):403-10. PubMed ID: 27355336
[TBL] [Abstract][Full Text] [Related]
6. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
7. Biomaterials-Mediated Engineering of the Immune System.
Backlund C; Jalili-Firoozinezhad S; Kim B; Irvine DJ
Annu Rev Immunol; 2023 Apr; 41():153-179. PubMed ID: 36696570
[TBL] [Abstract][Full Text] [Related]
8. Engineering self-assembled materials to study and direct immune function.
Tostanoski LH; Jewell CM
Adv Drug Deliv Rev; 2017 May; 114():60-78. PubMed ID: 28392305
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle-based autoimmune disease therapy.
Serra P; Santamaria P
Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
[TBL] [Abstract][Full Text] [Related]
10. Harnessing biomaterials to engineer the lymph node microenvironment for immunity or tolerance.
Andorko JI; Hess KL; Jewell CM
AAPS J; 2015 Mar; 17(2):323-38. PubMed ID: 25533221
[TBL] [Abstract][Full Text] [Related]
11. Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view.
Tajbakhsh A; Farahani N; Gheibihayat SM; Mirkhabbaz AM; Savardashtaki A; Hamblin MR; Mirzaei H
Int Immunopharmacol; 2021 Jan; 90():107177. PubMed ID: 33249046
[TBL] [Abstract][Full Text] [Related]
12. Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps.
Carey ST; Bridgeman C; Jewell CM
Adv Sci (Weinh); 2023 Mar; 10(8):e2205105. PubMed ID: 36638260
[TBL] [Abstract][Full Text] [Related]
13. Biomaterial-Driven Immunomodulation: Cell Biology-Based Strategies to Mitigate Severe Inflammation and Sepsis.
Lasola JJM; Kamdem H; McDaniel MW; Pearson RM
Front Immunol; 2020; 11():1726. PubMed ID: 32849612
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic manipulation of immune tolerance in allergic disease.
Akdis M; Akdis CA
Nat Rev Drug Discov; 2009 Aug; 8(8):645-60. PubMed ID: 19644474
[TBL] [Abstract][Full Text] [Related]
15. An introduction to biomaterial-based strategies for curbing autoimmunity.
Lewis JS; Allen RP
Exp Biol Med (Maywood); 2016 May; 241(10):1107-15. PubMed ID: 27229905
[TBL] [Abstract][Full Text] [Related]
16. Biomaterial-based approaches to engineering immune tolerance.
Emerson AE; Slaby EM; Hiremath SC; Weaver JD
Biomater Sci; 2020 Dec; 8(24):7014-7032. PubMed ID: 33179649
[TBL] [Abstract][Full Text] [Related]
17. Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.
Verhagen J; Wegner A; Wraith DC
Immunology; 2015 Jun; 145(2):171-81. PubMed ID: 25716063
[TBL] [Abstract][Full Text] [Related]
18. Bioengineering strategies for inducing tolerance in autoimmune diabetes.
Baekkeskov S; Hubbell JA; Phelps EA
Adv Drug Deliv Rev; 2017 May; 114():256-265. PubMed ID: 28625830
[TBL] [Abstract][Full Text] [Related]
19. Improving the clinical impact of biomaterials in cancer immunotherapy.
Gammon JM; Dold NM; Jewell CM
Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
[TBL] [Abstract][Full Text] [Related]
20. Biomaterials as Tools to Decode Immunity.
Eppler HB; Jewell CM
Adv Mater; 2020 Apr; 32(13):e1903367. PubMed ID: 31782844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
